Zephyrus Biosciences Company
Zephyrus Biosciences provides research tools to enable protein analysis at the single cell level. Addressing the burgeoning single-cell analysis market, our first product, the scWestern system, enables western blotting on individual cells for the first time. Researchers will utilize Zephyrus’s products to gain new insights into the biology of cancer, stem cells, neurology, and human disease and development.
Investors
Technology:
Regenerative Medicine
Industry:
Biotechnology, Hardware, Health Care
Headquarters:
Berkeley, California, United States
Founded Date:
2013-01-01
Employees Number:
1-10
Funding Status:
M&A
Investors Number:
10
Total Funding:
$1.9M
Last Funding Type:
Seed
Register and Claim Ownership